Medical Device Industry News

MassDevice.com +3 | The top 3 medtech stories for December 19, 2014

December 19, 2014 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Bio2 Technologies wins FDA nod for bioactive bone scaffolds

December 19, 2014 by Mark Hollmer

The FDA grants 510(k) clearance for Bio2 Technologies' CLM bioactive scaffold wedges.

Bio2 Technologies wins FDA nod for bioactive bone scaffolds

Massachusetts startup Bio2 Technologies plans a limited rollout in 2015 of its high-tech bioactive bone scaffold wedges, following the FDA's recent 510(k) clearance of the product.

Meridian Medical Technologies lands $130m Pentagon deal for nerve agent antidotes

December 19, 2014 by Mark Hollmer

The U.S. Defense Dept. agrees to pay Meridian Medical Technologies $130 million to develop auto-injectors that can deliver nerve agent antidotes.

Meridian Medical Technologies lands $130m Pentagon deal for nerve agent antidotes

Maryland's Meridian Medical Technologies is moving ahead with a whopping $129.5 million U.S. government contract to develop auto-injectors that can deliver nerve agent antidotes.

Medicare drops national coverage decisions for some lobotomies, tinnitus masking, others

December 19, 2014 by Brian Johnson

The Centers for Medicare & Medicaid Services will officially remove national coverage decisions for 7 procedures under a program initiated in November 2013, including stereotactic cingulotomy, tinnitus masking and more.

Medicare drops national coverage decisions for some lobotomies, tinnitus masking, others

The Centers for Medicare & Medicaid Services are removing national coverage decisions for 7 medical procedures, including certain types of lobotomies and tinnitus masking devices, after a year-long review initiated in November 2013.

Appeals court overturns triple damages in Stryker-Zimmer spat

December 19, 2014 by Brad Perriello

Zimmer is off the hook for the triple damages it owed Stryker after a patent infringement loss last year.

Appeals court overturns triple damages in Stryker-Zimmer spat

Diabetes: Medtronic advances closed-loop insulin pump

December 19, 2014 by Brad Perriello

Medtronic says it's done with a global user evaluation of a new closed-loop insulin pump with predictive low glucose management technology.

Diabetes: Medtronic advances closed-loop insulin pump

Medtronic (NYSE:MDT) said today that it's done with a global user evaluation program for a next-generation insulin pump system as it pursues the Holy Grail of diabetes: The artificial pancreas.

Pulmonx taps ex-Asthmatx CEO French for the corner office | Personnel Moves

December 19, 2014 by Brad Perriello

Pulmonx taps former Asthmatx CEO Glen French to be its new chief executive.

Pulmonx taps ex-Asthmatx CEO French for the corner office | Personnel Moves

Pulmonx said yesterday that it named Glen French, the co-founder and CEO of Asthmatx who led it to an acquisition by BSX, to be its new president and chief executive.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp